Analysis
IntegrativePractitioner.com industry analysis and commentary. Views expressed are of the authors only.
Robert Rountree, MD, joins Integrative Practitioner associate editor, Avery St. Onge, to discuss the different causes of irritable bowel syndrome,
… Read More
Semaglutide, tradename Ozempic, is an injectable drug that people with type 2 diabetes take weekly to control their blood sugar levels. It also
… Read More
Integrative Practitioner is pleased to offer the Complete Conference Package, featuring
Join Betsy Redmond, Ph.D., MMSc, RDN, on June 15 at 2 PM ET as she explains how to use the OMX™ Organic Metabolomics profile to identify
… Read More
A recent review article urged integrative practitioners to avoid certain natural medicine approaches to gastrointestinal health and detoxification,
… Read More
A new study indicated that the traditional Chinese herb, astragalus, may help significantly reduce inflammation in patients who’ve recently
… Read More
A recent study gave new insights into the cause of severe inflammatory bowel disease (IBD), identifying a genetic variant associated with an
… Read More
Findings from a recent study indicated that vitamin D levels in patients with advanced skin cancer may impact their response to immunotherapy
… Read More
SHARE